FN1 and non-small cell lung carcinoma: Moreover, given that β1 integrin is a major fibronectin-binding cell surface receptor and associated with a worse prognosis in NSCLC [19, 20], we therefore examined the expression change of β1 integrin in response to the knockdown or over-expression of 4.1N.